TABUTEAU HERRIOT
Chief Executive Officer · 36 insider transactions on file
All transactions
| Date | Ticker | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-07-01 | AXSM | Axsome Therapeutics, Inc. | Sale | 49,666 | $240.25 | $11.9M | filing |
| 2026-07-01 | AXSM | Axsome Therapeutics, Inc. | Option exercise | 49,666 | $4.95 | $245,846.70 | filing |
| 2026-06-09 | AXSM | Axsome Therapeutics, Inc. | Sale | 49,670 | $241.01 | $12.0M | filing |
| 2026-06-09 | AXSM | Axsome Therapeutics, Inc. | Option exercise | 49,670 | $4.95 | $245,866.50 | filing |
| 2026-02-02 | AXSM | Axsome Therapeutics, Inc. | Sale | 32,410 | $185.60 | $6.0M | filing |
| 2026-02-02 | AXSM | Axsome Therapeutics, Inc. | Option exercise | 32,410 | $8.02 | $259,928.20 | filing |
| 2026-01-07 | AXSM | Axsome Therapeutics, Inc. | Sale | 31,261 | $170.38 | $5.3M | filing |
| 2026-01-07 | AXSM | Axsome Therapeutics, Inc. | Option exercise | 31,261 | $8.02 | $250,713.22 | filing |
| 2026-01-06 | AXSM | Axsome Therapeutics, Inc. | Sale | 29,450 | $172.33 | $5.1M | filing |
| 2026-01-06 | AXSM | Axsome Therapeutics, Inc. | Option exercise | 29,450 | $8.02 | $236,189.00 | filing |
| 2026-01-05 | AXSM | Axsome Therapeutics, Inc. | Sale | 78,703 | $171.28 | $13.5M | filing |
| 2026-01-05 | AXSM | Axsome Therapeutics, Inc. | Option exercise | 78,703 | $8.02 | $631,198.06 | filing |
| 2025-12-04 | AXSM | Axsome Therapeutics, Inc. | Sale | 10,558 | $148.18 | $1.6M | filing |
| 2025-12-04 | AXSM | Axsome Therapeutics, Inc. | Option exercise | 10,558 | $8.02 | $84,675.16 | filing |
| 2025-12-03 | AXSM | Axsome Therapeutics, Inc. | Sale | 20,163 | $146.94 | $3.0M | filing |
| 2025-12-03 | AXSM | Axsome Therapeutics, Inc. | Option exercise | 20,163 | $8.02 | $161,707.26 | filing |
| 2025-12-02 | AXSM | Axsome Therapeutics, Inc. | Sale | 49,252 | $144.59 | $7.1M | filing |
| 2025-12-02 | AXSM | Axsome Therapeutics, Inc. | Option exercise | 49,252 | $8.02 | $395,001.04 | filing |
| 2025-11-05 | AXSM | Axsome Therapeutics, Inc. | Sale | 21,775 | $134.49 | $2.9M | filing |
| 2025-11-05 | AXSM | Axsome Therapeutics, Inc. | Option exercise | 21,775 | $8.02 | $174,635.50 | filing |
| 2025-11-04 | AXSM | Axsome Therapeutics, Inc. | Sale | 50,459 | $133.79 | $6.8M | filing |
| 2025-11-04 | AXSM | Axsome Therapeutics, Inc. | Option exercise | 50,459 | $8.02 | $404,681.18 | filing |
| 2025-11-03 | AXSM | Axsome Therapeutics, Inc. | Sale | 91,705 | $132.34 | $12.1M | filing |
| 2025-11-03 | AXSM | Axsome Therapeutics, Inc. | Option exercise | 91,705 | $8.02 | $735,474.10 | filing |
| 2025-10-08 | AXSM | Axsome Therapeutics, Inc. | Sale | 12,774 | $118.84 | $1.5M | filing |
| 2025-10-08 | AXSM | Axsome Therapeutics, Inc. | Option exercise | 12,774 | $8.02 | $102,447.48 | filing |
| 2025-10-07 | AXSM | Axsome Therapeutics, Inc. | Sale | 13,390 | $118.77 | $1.6M | filing |
| 2025-10-07 | AXSM | Axsome Therapeutics, Inc. | Option exercise | 13,390 | $8.02 | $107,387.80 | filing |
| 2025-10-06 | AXSM | Axsome Therapeutics, Inc. | Sale | 19,220 | $120.17 | $2.3M | filing |
| 2025-10-06 | AXSM | Axsome Therapeutics, Inc. | Option exercise | 19,220 | $8.02 | $154,144.40 | filing |
| 2025-09-16 | AXSM | Axsome Therapeutics, Inc. | Sale | 19,719 | $114.19 | $2.3M | filing |
| 2025-09-16 | AXSM | Axsome Therapeutics, Inc. | Option exercise | 19,719 | $8.02 | $158,146.38 | filing |
| 2025-09-15 | AXSM | Axsome Therapeutics, Inc. | Sale | 15,254 | $117.37 | $1.8M | filing |
| 2025-09-15 | AXSM | Axsome Therapeutics, Inc. | Option exercise | 15,254 | $8.02 | $122,337.08 | filing |
| 2025-09-12 | AXSM | Axsome Therapeutics, Inc. | Sale | 27,907 | $118.96 | $3.3M | filing |
| 2025-09-12 | AXSM | Axsome Therapeutics, Inc. | Option exercise | 27,907 | $8.02 | $223,814.14 | filing |
Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.